Track Phreesia, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Phreesia, Inc. PHR Open Phreesia, Inc. in new tab

8.84 USD
P/E
219.25
EPS
0.04
P/B
1.58
ROE
0.77
Beta
0.89
Target Price
15.39 USD
Phreesia, Inc. logo

Phreesia, Inc.

🧾 Earnings Recap – Q4 2026

Phreesia, Inc. demonstrated strong financial performance in FY 2026, achieving key milestones including over $100 million in Adjusted EBITDA and positive GAAP net income for the first time, positioning the company for continued growth.

  • Surpassed $100 million in Adjusted EBITDA and over $50 million in free cash flow.
  • Delivered positive GAAP net income for the first time in the company's publicly traded history.
  • Progressing on strategic growth initiatives with the acquisition of AccessOne and the launch of ProviderConnect.
  • Emphasis on AI to enhance operational efficiency and margin expansion.
  • Navigating challenges in the healthcare market, particularly impacting longer visibility into spending commitments.
📅
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateMay 28, 2026
P/E219.25
EPS0.04
Book Value5.56
Price to Book1.58
Debt/Equity30.38
% Insiders4.618%
Growth
Revenue Growth0.16%
Estimates
Forward P/E5.06
Forward EPS1.73
Target Mean Price15.39

DCF Valuation

Tweak assumptions to recompute fair value for Phreesia, Inc. (PHR)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Phreesia, Inc. Logo Phreesia, Inc. Analysis (PHR)

United States Health Care Official Website Stock

Is Phreesia, Inc. a good investment? Phreesia, Inc. (PHR) is currently trading at 8.84 USD. Market analysts have a consensus price target of 15.39 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 219.25. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Phreesia, Inc. is expected to release its next earnings report on May 28, 2026. The market consensus estimate for Forward EPS is 1.73.

Investor FAQ

Does Phreesia, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Phreesia, Inc.?

Phreesia, Inc. is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be May 28, 2026. The company currently has a trailing EPS of 0.04.

Company Profile

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions. It also offers PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare organizations including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest and not-for-profit and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.

Exchange Ticker
NYQ (United States) PHR
LSE (United Kingdom) 0A23.L
FRA (Germany) 19P.F

Dividends

Historical Split Corporate Actions

Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion